Thu, Jul 24, 2014, 1:22 AM EDT - U.S. Markets open in 8 hrs 8 mins

Recent

% | $
Click the to save as a favorite.

Insmed Incorporated Message Board

bohemianclubman 36 posts  |  Last Activity: Jul 2, 2014 3:20 PM Member since: May 19, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    03/31/2014 13F Filers holding this stock

    by dubl2dz Apr 30, 2014 7:22 PM
    bohemianclubman bohemianclubman May 8, 2014 7:00 PM Flag

    I didn't bash your straddle.... Simply said that using that strategy stood the possibility of leaving profits on the table if the share price heads up Everest on strong data.... but come on,, making a statement that buying a put is "the equivalent of being short the stock"..... you must have read an option starter pamphlet

  • Reply to

    03/31/2014 13F Filers holding this stock

    by dubl2dz Apr 30, 2014 7:22 PM
    bohemianclubman bohemianclubman May 8, 2014 5:34 PM Flag

    This message that I am responding to....one of many messages you are filling this board with,, tells us one thing for certain - You don't understand options.

  • Reply to

    short question(s)

    by michael_coen May 2, 2014 6:54 AM
    bohemianclubman bohemianclubman May 6, 2014 8:33 AM Flag

    Mike, about two or three years ago I actually called FINRA asking about that computation - It didn't make any sense to me. After a conversation that included questions and answers that only confused me further I came to the conclusion that the FINRA short data includes all sales other than market maker sales. JMO - I think the FINRA data is nearly useless...

  • Reply to

    Something brewing

    by jd39souza98 May 5, 2014 10:28 AM
    bohemianclubman bohemianclubman May 5, 2014 4:16 PM Flag

    H, I have never tried to e-mail them but have spoken to Anne Marie Fields several times - she has returned my calls. I have to admit that I'm one of those people that believes that e-mail has become to relied on, when one could just make an old fashioned phone call...

  • Reply to

    Greg Wade's intuition

    by b_leaguered May 2, 2014 8:43 PM
    bohemianclubman bohemianclubman May 2, 2014 8:48 PM Flag

    Great find BL...

  • Reply to

    OT : A special invite to Kevin and Evelyn

    by terry_insm May 2, 2014 3:12 PM
    bohemianclubman bohemianclubman May 2, 2014 3:35 PM Flag

    That post was actually pretty well written.......we should probably just ignore the fact that you are asking a poster on a message board....to fight!!!

  • Reply to

    Josh Schwimmer - Piper

    by bohemianclubman May 1, 2014 9:54 AM
    bohemianclubman bohemianclubman May 1, 2014 10:35 AM Flag

    Rook, I know, but when the entire sector is being punished it wil take company specific news to regain momentum. The FDA often surprises, but I have been through all I have been able to find regarding breakthrough therapy and I simply have drawn the conclusion that arikace for NTM will receive the designation. Even though there is a treatment for these patients that has simply been developed - not approved, only about half of the patients can tolerate the regimen. It's not like NTM is a disease that if something offers hope it can just be ignored because of the disease not being serious.....NTM is really awful...and growing quickly

  • Reply to

    Options Activity

    by biogenius722 Apr 30, 2014 6:16 PM
    bohemianclubman bohemianclubman May 1, 2014 10:17 AM Flag

    LOL, there is nothing at all wrong with your long the stock and short the calls and the puts scenario. I would not argue with the statement Pigs are USUALLY losers. I happen to believe that OHRP is one of those way beneath the radar stocks that has caused me to make the decision to be..... piggish. I could, of course, be wrong....

  • bohemianclubman by bohemianclubman May 1, 2014 9:54 AM Flag

    Of the hundreds of biotechs that trade he only follows 18. On March 14th he raised his price target on GWPH to 97 - the shares were trading just over 70. On April 15th, a month later, the share price fell under 42. In the 15 days since the shares have rose 35 points as the company received fast track status from the FDA. Insmed is waiting for breakthrough therapy designation from the FDA, which would automatically grant fast track. The current share price means nothing if INSM receives the positive nod from the FDA that this analyst is predicting.

  • Reply to

    Options Activity

    by biogenius722 Apr 30, 2014 6:16 PM
    bohemianclubman bohemianclubman May 1, 2014 9:31 AM Flag

    The only problem is that if the stock is 50 in October you make 8.50

  • Reply to

    Options Activity

    by biogenius722 Apr 30, 2014 6:16 PM
    bohemianclubman bohemianclubman Apr 30, 2014 7:48 PM Flag

    Thanks f.or pointing that out, I was watching the June options today, but not the July. BTW,, there were also 115 of the July 17.5 calls traded at 1.80 - which would require nearly exactly a double for the buyer to break even.

  • Reply to

    The Pests

    by dorianrivers21 Apr 30, 2014 9:37 AM
    bohemianclubman bohemianclubman Apr 30, 2014 4:10 PM Flag

    LOL,,, We are, of course, talking about imaginary numbers and imaginary profits, but you are correct - however it would then be 63% not 62%. Thanks for the correction though....

  • bohemianclubman by bohemianclubman Apr 30, 2014 1:25 PM Flag

    It's just a blog that anybody with decent writing ability can contribute to. Having read this MB for some time now, but rarely contributing, I have a suggestion: Livermore 10 should google "contributing to seeking alpha" - next he should follow the easy step by step instructions to contribute, and proceed to set the record straight.... those that contribute well read articles can even be paid. I'm not saying that LM10 is right about all he says, although I do hope time proves him correct - it's just that todays article while very much violating the facts, was also drafted by a short and disguised as an essay giving equal weight to the pros and cons of squalimine.

  • Reply to

    The Pests

    by dorianrivers21 Apr 30, 2014 9:37 AM
    bohemianclubman bohemianclubman Apr 30, 2014 9:50 AM Flag

    Dorian, the pest will never be gone - not even if INSM does go to $50. It is deeply personal with him and nobody would ever actually pay him a penny to post here. Paid posters sound intelligent and would never lose every ounce of credibility by bragging non-stop, day after day, sometimes minute after minute..... When all of clownboys posts were being deleted recently his behavior was borderline psychopathic....He is a very troubled thing and as hard as it is never to respond to him that is the path that I have chosen... with just one exception - mathematics - as in "I'm up 57%ytd and I made another 4% today and am now up 62%."

  • bohemianclubman bohemianclubman Apr 24, 2014 11:24 PM Flag

    NTM undoubtedly meets the criteria for a serious or life threatening condition, and a 25 percent cure rate certainly meets the criteria of clinical evidence of a substantial improvement of a significant endpoint. There don't appear any "shades of grey" here,, arikace should receive breakthrough therapy designation.... As for those claiming possible false negative cultures - three cultures were taken each time and grown for 6 weeks in order to alleviate any questions regarding potential false negatives .

  • bohemianclubman bohemianclubman Apr 24, 2014 12:03 PM Flag

    Thanks Michael, Do we know what date Insmed filed their request for breakthrough therapy designation? I knew approximizations but was unable to find an actual filing date. Thanks.

INSM
18.12+0.42(+2.37%)Jul 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Facebook, Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
Xilinx Inc.
NasdaqGSWed, Jul 23, 2014 4:00 PM EDT
TripAdvisor Inc.
NasdaqGSWed, Jul 23, 2014 3:59 PM EDT